the Zepbound question that gets asked weekly, answered properly
the Zepbound question that gets asked weekly, answered properly, and I am aware this is a minority view on this board.
Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.
26kg over 66 weeks, never went past 10mg, and muscle cramps stayed mild the whole way. Posting because the loud threads are all 15mg.
The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.
Ask me anything specific. Anything general I will probably get wrong.
best — the order this archive was captured in
Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.
This is the fifth "should I go up" post today and they are all welcome — but no member here can answer it for you.
the appetite effect is blunter than sema, in a good way, most weeks
[deleted]
Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.
The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.
Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state. Judging a new step at day five is judging noise.
Not sure that follows. You went up a step and changed your training in the same fortnight.
Right. And the sema-to-tirz "conversion" people post is invented. There is no published equivalence.
2.5 is the starter dose and it is not meant to be the dose that works
What is the waist doing? That is usually the number still moving during a scale stall.
Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.
Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.
That percentage is body weight change, not body fat. Different measurement, and the distinction gets lost every time.
2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.
SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.
Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.
Push back: "gentler than sema" is a population statement.
Saving this one. It is the clearest statement of the stall problem I have read here.
sulphur burps are the signature complaint and they are not dangerous
sulphur burps are the signature complaint and they are not dangerous
This. The step interval is a floor, and reading it as a timetable is the most expensive mistake in the thread.
This.
Not sure about this bit. The GIP arm being real does not tell you that it is what caused your particular week.
hold the dose that works, the ladder is not a leaderboard
Which week did the appetite change actually land for you?
- 1Weekly dosing again, half-life in the same neighbourhood as sema, so a step…9 comments in this branch · started by u/britt_okwuosa
- 2Push back: "gentler than sema" is a population statement. Plenty of people…7 comments in this branch · started by u/zeynep_ndiaye